An analysis of 32 cancer drugs approved by the European Medicines Agency between 2014 and 2016 has found that only 9 of them were supported by … Continue reading Regulatory Approval For Cancer Drugs Based On ‘Biased’ And ‘Exaggerated’ Evidence